SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-014914
Filing Date
2023-05-02
Accepted
2023-05-02 17:07:31
Documents
26
Period of Report
2023-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20230502.htm   iXBRL 8-K 40390
2 EX-99.1 aqst-q1x2023xex991earnings.htm EX-99.1 176502
3 EX-99.2 q12023supplementalearnin.htm EX-99.2 13993
7 aqstlogoa.jpg GRAPHIC 14528
8 q12023supplementalearnin001.jpg GRAPHIC 101063
9 q12023supplementalearnin002.jpg GRAPHIC 303785
10 q12023supplementalearnin003.jpg GRAPHIC 122292
11 q12023supplementalearnin004.jpg GRAPHIC 81479
12 q12023supplementalearnin005.jpg GRAPHIC 58949
13 q12023supplementalearnin006.jpg GRAPHIC 62128
14 q12023supplementalearnin007.jpg GRAPHIC 57858
15 q12023supplementalearnin008.jpg GRAPHIC 71243
16 q12023supplementalearnin009.jpg GRAPHIC 50551
17 q12023supplementalearnin010.jpg GRAPHIC 61742
18 q12023supplementalearnin011.jpg GRAPHIC 48425
  Complete submission text file 0001628280-23-014914.txt   1815852

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20230502.xsd EX-101.SCH 1893
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20230502_lab.xml EX-101.LAB 24831
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20230502_pre.xml EX-101.PRE 13037
20 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20230502_htm.xml XML 11254
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 23880300
SIC: 2834 Pharmaceutical Preparations